353 related articles for article (PubMed ID: 32928659)
1. Clinically Meaningful Reduction in Dyspareunia Is Associated With Significant Improvements in Health-Related Quality of Life Among Women With Moderate to Severe Pain Associated With Endometriosis: A Pooled Analysis of Two Phase III Trials of Elagolix.
Agarwal SK; Soliman AM; Pokrzywinski RM; Snabes MC; Coyne KS
J Sex Med; 2020 Dec; 17(12):2427-2433. PubMed ID: 32928659
[TBL] [Abstract][Full Text] [Related]
2. Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: analysis of 2 phase III clinical trials.
Pokrzywinski RM; Soliman AM; Chen J; Snabes MC; Coyne KS; Surrey ES; Taylor HS
Am J Obstet Gynecol; 2020 Jun; 222(6):592.e1-592.e10. PubMed ID: 31759891
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies.
Surrey E; Taylor HS; Giudice L; Lessey BA; Abrao MS; Archer DF; Diamond MP; Johnson NP; Watts NB; Gallagher JC; Simon JA; Carr BR; Dmowski WP; Leyland N; Singh SS; Rechberger T; Agarwal SK; Duan WR; Schwefel B; Thomas JW; Peloso PM; Ng J; Soliman AM; Chwalisz K
Obstet Gynecol; 2018 Jul; 132(1):147-160. PubMed ID: 29889764
[TBL] [Abstract][Full Text] [Related]
4. Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.
Becker CM; Johnson NP; As-Sanie S; Arjona Ferreira JC; Abrao MS; Wilk K; Imm SJ; Mathur V; Perry JS; Wagman RB; Giudice LC
Hum Reprod; 2024 Mar; 39(3):526-537. PubMed ID: 38243752
[TBL] [Abstract][Full Text] [Related]
5. Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients.
Abrao MS; Surrey E; Gordon K; Snabes MC; Wang H; Ijacu H; Taylor HS
BMC Womens Health; 2021 Jun; 21(1):246. PubMed ID: 34134684
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
Taylor HS; Giudice LC; Lessey BA; Abrao MS; Kotarski J; Archer DF; Diamond MP; Surrey E; Johnson NP; Watts NB; Gallagher JC; Simon JA; Carr BR; Dmowski WP; Leyland N; Rowan JP; Duan WR; Ng J; Schwefel B; Thomas JW; Jain RI; Chwalisz K
N Engl J Med; 2017 Jul; 377(1):28-40. PubMed ID: 28525302
[TBL] [Abstract][Full Text] [Related]
7. Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix.
Taylor HS; Soliman AM; Johns B; Pokrzywinski RM; Snabes M; Coyne KS
Obstet Gynecol; 2020 Sep; 136(3):501-509. PubMed ID: 32769633
[TBL] [Abstract][Full Text] [Related]
8. Impact of elagolix treatment on fatigue experienced by women with moderate to severe pain associated with endometriosis.
Surrey ES; Soliman AM; Agarwal SK; Snabes MC; Diamond MP
Fertil Steril; 2019 Aug; 112(2):298-304.e3. PubMed ID: 30992150
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness Evaluation and Recommendation for Responder Thresholds for Endometriosis Health Profile-30: Analysis of Two Phase III Clinical Trials.
Pokrzywinski R; Soliman AM; Chen J; Snabes MC; Taylor HS; Coyne KS
J Womens Health (Larchmt); 2020 Feb; 29(2):253-261. PubMed ID: 31855102
[No Abstract] [Full Text] [Related]
10. Impact of elagolix on work loss due to endometriosis-associated pain: estimates based on the results of two phase III clinical trials.
Pokrzywinski RM; Soliman AM; Chen J; Snabes M; Diamond MP; Surrey E; Coyne KS
Fertil Steril; 2019 Sep; 112(3):545-551. PubMed ID: 31227284
[TBL] [Abstract][Full Text] [Related]
11. Impact of Elagolix on Workplace and Household Productivity Among Women with Moderate to Severe Pain Associated with Endometriosis: A Pooled Analysis of Two Phase III Trials.
Surrey ES; Soliman AM; Palac HL; Agarwal SK
Patient; 2019 Dec; 12(6):651-660. PubMed ID: 31654294
[TBL] [Abstract][Full Text] [Related]
12. Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis-Associated Pain: An Application of Markov Model.
Winzenborg I; Polepally AR; Nader A; Mostafa NM; Noertersheuser P; Ng J
CPT Pharmacometrics Syst Pharmacol; 2020 Aug; 9(8):466-475. PubMed ID: 32621325
[TBL] [Abstract][Full Text] [Related]
13. Endometriosis-Related Pain Reduction During Bleeding and Nonbleeding Days in Women Treated with Elagolix.
Agarwal SK; Singh SS; Archer DF; Mai Y; Chwalisz K; Gordon K; Surrey E
J Pain Res; 2021; 14():263-271. PubMed ID: 33564263
[TBL] [Abstract][Full Text] [Related]
14. Prospective Cohort of Deep Dyspareunia in an Interdisciplinary Setting.
Yong PJ; Williams C; Bodmer-Roy S; Ezeigwe C; Zhu S; Arion K; Ambacher K; Yosef A; Wong F; Noga H; Britnell S; Yager H; Bedaiwy MA; Brotto LA; Albert AY; Lisonkova S; Allaire C
J Sex Med; 2018 Dec; 15(12):1765-1775. PubMed ID: 30446474
[TBL] [Abstract][Full Text] [Related]
15. A Clinician's Guide to the Treatment of Endometriosis with Elagolix.
Leyland N; Estes SJ; Lessey BA; Advincula AP; Taylor HS
J Womens Health (Larchmt); 2021 Apr; 30(4):569-578. PubMed ID: 32975461
[TBL] [Abstract][Full Text] [Related]
16. Cross-Sectional Survey of the Impact of Endometriosis Symptoms on Health-Related Quality of Life in Canadian Women.
Soliman AM; Singh S; Rahal Y; Robert C; Defoy I; Nisbet P; Leyland N
J Obstet Gynaecol Can; 2020 Nov; 42(11):1330-1338. PubMed ID: 32758398
[TBL] [Abstract][Full Text] [Related]
17. Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study.
Carr B; Giudice L; Dmowski WP; O'Brien C; Jiang P; Burke J; Jimenez R; Hass S; Fuldeore M; Chwalisz K
J Endometr Pelvic Pain Disord; 2013 Jul; 5(3):105-115. PubMed ID: 30320043
[TBL] [Abstract][Full Text] [Related]
18. Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study.
Diamond MP; Carr B; Dmowski WP; Koltun W; O'Brien C; Jiang P; Burke J; Jimenez R; Garner E; Chwalisz K
Reprod Sci; 2014 Mar; 21(3):363-71. PubMed ID: 23885105
[TBL] [Abstract][Full Text] [Related]
19. Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials.
Samy A; Taher A; Sileem SA; Abdelhakim AM; Fathi M; Haggag H; Ashour K; Ahmed SA; Shareef MA; AlAmodi AA; Keshta NHA; Shatat HBAE; Salah DM; Ali AS; El Kattan EAM; Elsherbini M
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101798. PubMed ID: 32479894
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of the oral gonadotropin-releasing hormone-antagonist elagolix for the management of endometriosis-associated pain.
Taylor HS; Dun EC; Chwalisz K
Pain Manag; 2019 Sep; 9(5):497-515. PubMed ID: 31434540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
